Symptom-dependent cut-offs of urine metanephrines improve diagnostic accuracy for detecting pheochromocytomas in two separate cohorts, compared to symptom-independent cut-offs

• Published in: Endocrine Vol. 54; no. 1; pp. 206 - 216
• Main Authors: Cho, Yoon Young, Song, Kee-Ho, Kim, Young Nam, Ahn, Seong Hee, Kim, Hyeonmok, Park, Sooyoun, Suh, Sunghwan, Kim, Beom-Jun, Lee, Soo-Youn, Chun, Sail, Koh, Jung-Min, Lee, Seung Hun, Kim, Jae Hyeon
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.10.2016; Springer Nature B.V
• Subjects: Accuracy; Adrenal Gland Neoplasms - diagnosis; Adrenal Gland Neoplasms - surgery; Adrenal Gland Neoplasms - urine; Adrenalectomy; Adult; Aged; Diabetes; Endocrinology; Female; Females; Humanities and Social Sciences; Humans; Internal Medicine; Male; Males; Medicine; Medicine & Public Health; Metanephrine - urine; Middle Aged; multidisciplinary; Normetanephrine - urine; Original Article; Pheochromocytoma; Pheochromocytoma - diagnosis; Pheochromocytoma - surgery; Pheochromocytoma - urine; Science; Sensitivity and Specificity; Urine; Pheochromocytoma; Symptom; Urine metanephrine; Republic of Korea
• ISSN: 1355-008X; 1559-0100
• DOI: 10.1007/s12020-016-1049-8

The development of advanced imaging techniques has increased the detection of subclinical pheochromocytomas. Because of the substantial proportions of subclinical pheochromocytomas, measurement of urine metanephrine concentrations is crucial due to detect or exclude pheochromocytoma. Although urine metanephrines are elevated in symptomatic subjects, diagnostic cut-offs according to the presence of adrenergic symptoms have not been studied. Pheochromocytomas patients who underwent adrenalectomy at Samsung Medical Center and a control group were compared to determine cut-off concentrations of urine metanephrines. An independent population was analyzed for urine metanephrines with different kits to validate the improvement in diagnostic accuracy using adjusted cut-offs. Symptom-dependent cut-offs of urine metanephrines were higher for symptomatic patients (307 μg/day in males, 235 μg/day in females for urine metanephrine, and 1,045 μg/day in males and 457 μg/day in females for urine normetanephrine) than for asymptomatic patients (206 μg/day in males, 199 μg/day in females for urine metanephrine, and 489 μg/day in males and 442 μg/day in females for urine normetanephrine). Symptom-dependent cut-offs of urine metanephrines improved a specificity from 92.7 % to 96.3 % and a high sensitivity of 97.8 % was maintained. Using the Symptom-dependent cut-offs raised diagnostic accuracy by 5.5 % ( p  <0.001). Similar trend was also observed in an independent population using different hormone kits. Using symptom-dependent cut-offs of urine metanephrines in symptomatic patients for pheochromocytomas resulted in a significant improvement in diagnostic accuracy in two separate cohorts.